NSE: BIOFILCHEM · PHARMACEUTICALS

Biofil Chemicals & Pharmaceuticals Limited Share Price & Company Info

₹30.67-2.29%

End-of-day price, · Educational content, not investment advice

52W low ₹25.6052W high ₹46.34
Market cap
₹46.67 Cras reported by NSE
52-week high
₹46.3404-FEB-2026
52-week low
₹25.6030-MAR-2026
P/E (NSE)
96.41
Face value
₹10.00
Shares issued
1,62,73,800
Volume
29,057₹0.09 Cr traded
Delivery
67.21%of traded quantity
Price band
20%₹23.53 – ₹35.29 on 2026-11-02
Annual volatility
58.08%NSE, from daily returns
Series
EQrolling settlement
BSE group
Bscrip code 524396
ISIN
INE829A01014
Listed on NSE
12-Jun-1996

About Biofil Chemicals & Pharmaceuticals Limited

Biofil Chemicals & Pharmaceuticals Limited is listed on the National Stock Exchange of India under the symbol BIOFILCHEM in the EQ series. NSE classifies it under the basic industry Pharmaceuticals, part of the Healthcare sector. Its shares were listed on NSE on 12-Jun-1996. Each share has a face value of ₹10.00.

In the end-of-day data for 16 November 2026 the stock closed at ₹30.67, down 2.29% on the day. NSE puts the company's market capitalisation at about ₹46.67 crore, which puts it among the smallest listed companies in India. Over the past 52 weeks it has traded between ₹25.60 and ₹46.34, so the last price is 19.8% above the low and 33.8% below the high.

29,057 shares changed hands that day, and 67.21% of them were taken as delivery rather than squared off intraday. A high delivery share means most of the day's buyers chose to hold the shares; a low one usually means the volume was mostly short-term trading.

EQ is the normal equity series: shares settle on the usual T+1 cycle and intraday trading is allowed.

NSE currently lists a regulatory note for this stock: “Scrip PE is greater than 50 for prev. 4 trailing Qtrs. | Less than 100 unique PAN traded in prev. 30 days”. Notes like these come from the exchange's surveillance and disclosure checks and can mean higher margins, trade-for-trade settlement or limits on trading. Check the NSE quote page for the current position before trading.

NSE puts the stock's annualised volatility at 58.08%. That is well above the level of large, established companies, so double-digit swings within a month are common.

Because the share trades below ₹50, it also appears in our list of penny stocks under ₹50, which explains the extra risks that come with low-priced shares.

Biofil Chemicals & Pharmaceuticals Limited quarterly results

In the quarter ended June 2026 (un-audited), Biofil Chemicals & Pharmaceuticals Limited reported total income of ₹12.41 crore and a net profit of ₹0.11 crore, or ₹0.07 per share. That is a net margin of 0.9% on income.

A year earlier, in the June 2025 quarter, income was ₹9.26 crore with a net profit of ₹2.41 crore. Income has grown 34.0% year on year. Net profit has fallen 95.4%.

Biofil Chemicals & Pharmaceuticals Limited was profitable in 5 of the 5 quarters shown below, every one of them. Figures are as filed with NSE, in ₹ crore.

Quarterly results filed with NSE (₹ crore, EPS in ₹)
Quarter endedTotal incomeProfit before taxNet profitEPSStatus
June 202612.410.130.110.07Un-Audited
March 20267.670.470.210.13Audited
December 20250.930.110.080.05Un-Audited
September 202513.600.110.080.05Un-Audited
June 20259.262.762.411.48Un-Audited

Biofil Chemicals & Pharmaceuticals Limited shareholding pattern

At the end of September 2026, promoters and the promoter group held 46.79% of Biofil Chemicals & Pharmaceuticals Limited, with the public holding 53.21%. That is down 0.03 percentage points from 46.82% in December 2024.

Shareholding by category, as filed with NSE each quarter
Quarter endedPromoter & Promoter Group (%)Public (%)
September 202646.7953.21
June 202646.7953.21
March 202646.7953.21
December 202546.7953.21
September 202546.7953.21
June 202546.8253.18
March 202546.8253.18
December 202446.8253.18

Biofil Chemicals & Pharmaceuticals Limited share price performance

Over the past year the Biofil Chemicals & Pharmaceuticals Limited share price has lost 24.86%, against a fall of 10.92% for the NIFTY 50, so it has underperformed that index by 13.94 percentage points.

Across the 7 periods in the table, the stock did not beat the NIFTY 50 in any of them. Past returns describe what happened; they do not predict what comes next.

Price change by period, as of 2026-11-02 (NSE)
PeriodBIOFILCHEMNIFTY 50
1 month-4.58%+1.91%
3 months-9.55%-5.20%
6 months-14.86%-3.94%
1 year-24.86%-10.92%
2 years-56.83%-5.29%
3 years-39.16%+20.44%
5 years-52.55%+30.45%

Biofil Chemicals & Pharmaceuticals Limited vs industry peers

NSE compares Biofil Chemicals & Pharmaceuticals Limited with 6 other listed companies in Pharmaceuticals. By market capitalisation it ranks 4 of 7.

Its P/E of 96.41 compares with a median of 21.22 for the other companies in the group: the market is paying considerably more for each rupee of its recent earnings.

NSE industry peer comparison, results for JUN 2026 quarter (₹ crore)
CompanyMarket capPrice (₹)P/EPromoter %Qtr incomeQtr net profit
JFLLIFE64.679.8026.3567.4711.121.11
ZENITHDRUG63.4537.0016.090.00——
SUNLOC63.1261.55—0.00——
BIOFILCHEM47.1828.9996.4146.7912.410.11
VIVIMEDLAB45.855.53—0.00——
MANGALAM45.2528.59—35.6557.23-7.55
NATCO-RE44.2725.95—0.00——

Biofil Chemicals & Pharmaceuticals Limited announcements, board meetings and corporate actions

Latest announcements

The most recent filings Biofil Chemicals & Pharmaceuticals Limited has made with NSE, newest first:

  • 06-Oct-2026 · Certificate under SEBI (Depositories and Participants) Regulations, 2018: Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 (PDF)
  • 24-Sep-2026 · Trading Window: Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (PDF)
  • 24-Sep-2026 · Change in Management: Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about disclosure as required under sub-clause 7 of Para A of Part A of Schedule III regarding 1. Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-Executive Independent Director of the Company, upon attaining the age of 75 (seventy-five) years. (PDF)
  • 24-Sep-2026 · Shareholders meeting: Biofil Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 23, 2026. Further, the company has informed the Exchange regarding voting results. (PDF)
  • 23-Sep-2026 · Shareholders meeting: Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 23, 2026 (PDF)
  • 28-Aug-2026 · Copy of Newspaper Publication: Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication Pursuant to Regulation 30, 44 and 47 of SEBI (LODR) Regulations, 2015 and in compliance with section 108 of the Companies Act, 2013 read with rule 20 of the Companies (Management and Administration) Rules, 2014. (PDF)
  • 26-Aug-2026 · General Updates: Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about about intimation of e-voting for 41st Annual General Meeting (PDF)
  • 26-Aug-2026 · General Updates: Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about draft letter to be dispatched to members whose email addresses not registered with the company/ depository participants (PDF)

Board meetings

  • 11-Aug-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
  • 30-May-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended March 31, 2026 and other business matters
  • 13-Feb-2026 · Financial Results: 1. To consider and approve the financial results for the period ended December 31, 2025 along with Limited Review Report thereon. 2.To consider other routine matters with the permission of the chair.
  • 13-Nov-2025 · Financial Results: To consider and approve the financial results for the period ended September 30, 2025
  • 12-Aug-2025 · Financial Results: To consider and approve the financial results for the period ended Jun 30, 2025

Corporate actions

None of the corporate actions on record is a dividend, split or bonus issue; they are meetings and book closures. The ex-date is the first day the shares trade without the entitlement.

  • Annual General Meeting · ex-date 23-Sep-2024 · book closure 24-Sep-2024 to 30-Sep-2024
  • Annual General Meeting · ex-date 20-Sep-2023 · book closure 21-Sep-2023 to 27-Sep-2023
  • Annual General Meeting · ex-date 21-Sep-2022 · book closure 23-Sep-2022 to 30-Sep-2022
  • Annual General Meeting · ex-date 17-Sep-2021 · book closure 21-Sep-2021 to 27-Sep-2021
  • Annual General Meeting · ex-date 21-Sep-2020 · book closure 23-Sep-2020 to 29-Sep-2020
  • Annual General Meeting · ex-date 18-Sep-2019 · book closure 20-Sep-2019 to 26-Sep-2019
  • Annual General Meeting · ex-date 18-Sep-2018 · book closure 21-Sep-2018 to 27-Sep-2018
  • Annual General Meeting · ex-date 14-Sep-2017 · book closure 18-Sep-2017 to 25-Sep-2017
  • Annual General Meeting · ex-date 22-Sep-2016 · book closure 24-Sep-2016 to 28-Sep-2016
  • Annual General Meeting · ex-date 16-Sep-2015 · book closure 19-Sep-2015 to 24-Sep-2015

Risk notice: low-priced and small-company shares can be illiquid, volatile and subject to manipulation, and shareholders can lose their entire investment. This page is a factual summary, not a recommendation to buy or sell Biofil Chemicals & Pharmaceuticals Limited.

Where to find Biofil Chemicals & Pharmaceuticals Limited's financials

Direct downloads from NSE:

For full financial statements, shareholding detail and every company announcement, go to the source:

Other Pharmaceuticals stocks on MCX Trends

Frequently asked questions

What is the Biofil Chemicals & Pharmaceuticals Limited share price?

Biofil Chemicals & Pharmaceuticals Limited (NSE: BIOFILCHEM) closed at ₹30.67 in the end-of-day data for 16 November 2026. For a live price, use the NSE quote page or your broker, because this page is updated from end-of-day files.

Which sector does Biofil Chemicals & Pharmaceuticals Limited belong to?

NSE classifies Biofil Chemicals & Pharmaceuticals Limited under Pharmaceuticals, in the Healthcare sector.

What is the 52-week high and low of BIOFILCHEM?

The 52-week high is ₹46.34 (04-FEB-2026) and the 52-week low is ₹25.60 (30-MAR-2026), according to NSE.

Is Biofil Chemicals & Pharmaceuticals Limited a penny stock?

At ₹30.67 the share trades below ₹50, so it appears on our list of penny stocks under ₹50. A low share price on its own says nothing about whether a company is cheap or expensive; market capitalisation, debt, profits and exchange surveillance status matter far more.

What is the promoter holding in Biofil Chemicals & Pharmaceuticals Limited?

Promoters and the promoter group held 46.79% of Biofil Chemicals & Pharmaceuticals Limited at the end of September 2026, according to the shareholding pattern filed with NSE.

What were Biofil Chemicals & Pharmaceuticals Limited's latest quarterly results?

For the quarter ended June 2026, Biofil Chemicals & Pharmaceuticals Limited reported total income of ₹12.41 crore and a net profit of ₹0.11 crore (EPS ₹0.07).

Where can I find Biofil Chemicals & Pharmaceuticals Limited's annual report and financial results?

Annual reports, quarterly results and other filings are published on the NSE corporate filings pages (search for BIOFILCHEM) and on BSE. Screener also lays out several years of financial statements in one place. Links to all of these are above.

More on MCX Trends